Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

diffuse large B-cell lymphoma activated B-cell type - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

diffuse large B-cell lymphoma activated B-cell type

MONDO:0850418

Find Clinical TrialsTrials

Overview

A diffuse large B-cell lymphoma that is characterized by the expression of CD44, PKCbeta1, Cyclin D2, BCL-2, and IRF4/MUM1 genes.

Clinical Trials6 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for diffuse large B-cell lymphoma activated B-cell type has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

6 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, procedural interventions, biologic therapy, and other interventions. Pipeline includes 1 PHASE3, 3 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT04512716](https://clinicaltrials.gov/study/NCT04512716)

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:52 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 6 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Laboratory research	11	39%
Research summaries	5	18%
Patient case studies	3	11%
New treatment approaches	3	11%
Testing and diagnosis research	2	7%
Clinical study results	2	7%
Other research	1	4%
Disease patterns and progression	1	4%

diffuse large B-cell lymphoma activated B-cell type

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications